A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: George J Weiner Matthew J. Maurer Clive S Zent Brian K Link Tait D Shanafelt Zuhair K Ballas |
| Publication date | June 12, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |